文献速递类风湿关节炎

下一代类风湿因子检测对高危人群关节炎发生的预测能力提升

Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at risk.
PubMed 文献 · RMD Open · 2024-08-20

在475例血清阳性(IgM-RF或aCCP阳性)关节痛患者的前瞻性队列中随访5年或至关节炎发生,评估针对RA相关表位的IgM-RF(T3-17)的预测价值。T3-17 RF阳性者关节炎发生风险HR=3.2(95%CI 2.4-4.3),高于野生型RF的HR=2.2(95%CI 1.7-3.0);与aCCP滴度联合时HR=6.4(4.7-8.7),优于单用aCCP。作者认为疾病特异性RF检测可行,似可提升RF诊断能力,应考虑在临床中实施。

要点

  • 在血清阳性关节痛患者中,T3-17 RF阳性者关节炎发生风险高于野生型RF。
  • T3-17 RF联合aCCP滴度的预测能力优于单用aCCP检测。
  • 作者认为疾病特异性RF检测可行,应考虑在临床中实施。

核心结论

  • 疾病特异性RF检测可行,似可提升RF的诊断能力,应考虑在临床中实施。

研究设计与样本

  • 前瞻性队列研究,纳入475例血清阳性(IgM-RF或aCCP阳性)关节痛患者,随访5年或至关节炎发生,检测针对RA相关表位的IgM-RF(下一代RF抗原T3-17)。

主要发现

  • T3-17 RF阳性组关节炎发生风险HR=3.2(95%CI 2.4-4.3),野生型RF组HR=2.2(95%CI 1.7-3.0)。
  • T3-17 RF联合aCCP滴度的HR=6.4(95%CI 4.7-8.7),单用aCCP的HR=5.1(95%CI 3.9-6.8)。
  • T3-17 RF联合aCCP的预测表现优于单用aCCP检测。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Rheumatoid arthritis (RA) is characterised by the presence of autoantibodies, among which those targeting the constant region of immunoglobulin G (IgG), called rheumatoid factors (RF). Despite this link, RFs can also be found in other disorders and the healthy population, which hampers its use as a diagnostic tool. We recently showed that a subset of RA-derived RFs target a distinct epitope on the IgG-Fc, a feature that is currently not used in the clinic. METHODS: We determined immunoglobulin M (IgM)-RF levels specific against an RA-associated epitope (using our engineered next-generation RF antigen 'T3-17') in a prospective cohort of 475 patients with seropositive (for IgM-RF or aCCP) arthralgia that were followed for 5 years or until the development of arthritis. RESULTS: The presence of RFs targeting T3-17 was more strongly associated with progression to arthritis in comparison to traditional RF measurements. Within the group of patients positive for T3-17 RF the risk of arthritis development was increased as compared with wild-type RF, HR=3.2 (95% CI 2.4 to 4.3) vs HR=2.2 (95% CI 1.7 to 3.0). Predictive power of T3-17 RF was improved in combination with aCCP titres, HR=6.4 (4.7-8.7) vs HR=5.1 (3.9-6.8). This combination performed better than aCCP detection on its own. CONCLUSION: The detection of disease-specific RF is feasible and seems to improve the diagnostic power of RF and should be considered to be implemented in the clinic.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Oskam N, Ooijevaar-de Heer P, Kos D, et al. Next-generation rheumatoid factor assay provides improved predictive power for the development of arthritis in patients at risk. RMD Open. 2024. PMID: 39164049. doi:10.1136/rmdopen-2024-004172

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。